1. Home
  2. Labeler Index
  3. Fenwal, Inc.
  4. 0942-6322
  5. Product Images: Cpda-1

Product Images Cpda-1

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 10 images provide visual information about the product associated with Cpda-1 NDC 0942-6322 by Fenwal, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Anticoagulant Citrate Phosphate Dextrose Adenine Solution, USP (CPDA-1) BLOOD-PACK Unit with Elongated Primary Container label - c225c6cc 620c 43c1 8ad2 777c82aacd87 10

Anticoagulant Citrate Phosphate Dextrose Adenine Solution, USP (CPDA-1) BLOOD-PACK Unit with Elongated Primary Container label - c225c6cc 620c 43c1 8ad2 777c82aacd87 10

This is a description of a blood-pack unit labeled with code 4R1250. The set includes 3 units of quadruple anticoagulant citrate phosphate dextrose adenine solution with elongated primary container featuring a sample diversion system and a 16 ga. ultra-thin wall Fenwal HighFlo Needle. The solution contains 63mL of CPDA-1 solution having 2g dextrose monohydrate USP, 1.6g Sodium Citrate dihydrate USP, 188mg citric acid anhydrous USP, 140mg monobasic sodium phosphate monohydrate USP, and 17.3mg Adenine USP. The pH of the solution might have been adjusted with sodium hydroxide. There are empty transfer pack containers included as well. The set is sterile, and the fluid path is non-pyrogenic; it is for single use only. It should be stored at a controlled room temperature, protected from freezing and excessive heat, and the instruction manual must be read before use. The manufacturer is Fresenius Kabl AG, located in Germany, and the product is made in the US. Instructions on the handling of the product surfaces, storage conditions, and the duration of use are provided.*

export 00

export 00

This is an instructional guide for loading the centrifuge cup for blood processing. It explains the steps involved in loading the containers, inserting the Y-connector, and placing the bags in the primary container. It also provides precautions and warnings, like the use of recommended blood bag inserts and avoiding excessive space inside the cup. Variations in stacking order and techniques depending on the facility's standard operating procedures are also mentioned. Finally, it is advised to perform the centrifugation following standard procedures.*

export 01

export 01

export 02

export 02

This text appears to be a set of instructions or labels related to a medical device. It includes cautionary language, information about sterilization by steam, and a warning not to reuse the device. It is unclear what specific device or equipment this text pertains to.*

export 03

export 03

export 04

export 04

This is a table showing the method of adding a Glyceroiyte 57 solution to red cell concentrates. The table lists various weights and amounts of glycerol added to the units. The information reflects the gross weight of the unit, net weight, initial addition of glycerol, second addition, third addition, and total amount of glycerol added. The text also includes a note on the tare weight of the primary container and the transfer pack container of approximately 72 grams.*

export 05

export 05

export 06

export 06

export 07

export 07

export 08

export 08

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.